Zaleplon Capsule
Product Images NDC 43063-505

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zaleplon (NDC 43063-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063505 Label (43063505)

43063505 Label (43063505)
This is a medication called Zaleplon. It is advised that individuals taking this medication should not consume alcohol as it can cause drowsiness. Additionally, caution is recommended when performing activities that require mental alertness. Federal law restricts the transfer of this drug to anyone other than the person it was prescribed for. The scanned batch numbers and other details on packaging may not have been read properly as they are not legible. One capsule of Zaleplon 5mg is to be taken three times a day. It is important to seek medical advice if one experiences any side effect. This medication is manufactured by Aurobindo Pharma Ltd in India and packaged by PD-Rx Pharmaceuticals Inc in Oklahoma City.*
FDA Label Image

Chemical Structure (Zaleplon Str)

Chemical Structure (Zaleplon Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.